blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3304041

EP3304041 - METHODS OF ASSESSING CELLULAR BREAST SAMPLES AND COMPOSITIONS FOR USE IN PRACTICING THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.01.2022
Database last updated on 12.11.2024
FormerThe patent has been granted
Status updated on  05.02.2021
FormerGrant of patent is intended
Status updated on  22.09.2020
FormerExamination is in progress
Status updated on  12.06.2019
FormerRequest for examination was made
Status updated on  09.03.2018
FormerThe international publication has been made
Status updated on  02.12.2016
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
IncellDx, Inc.
1700 El Camino Real
Menlo Park CA 94027 / US
[2018/15]
Inventor(s)01 / SHULTS, Keith
9825 Sam Donald Road
Nolensville, Tennessee 37135 / US
02 / CHARGIN, Amanda Noel
2133 Los Coches Avenue
San Jose, California 95128 / US
03 / JAFARIANMOHAMADY, Seyedhamed
1379 Down River Drive
Memphis, Tennessee 38103 / US
 [2018/26]
Former [2018/15]01 / SHULTS, Keith
9825 Sam Donald Road
Nolensville, Tennessee 37135 / US
02 / CHARGIN, Amanda Noel
11 Jackson Street
San Jose, California 95112 / US
03 / JAFARIANMOHAMADY, Seyedhamed
1379 Down River Drive
Memphis, Tennessee 38103 / US
Representative(s)Duxbury, Stephen
Arnold & Siedsma
Bavariaring 17
80336 München / DE
[2018/15]
Application number, filing date16800679.925.05.2016
[2018/15]
WO2016US34195
Priority number, dateUS201562166583P26.05.2015         Original published format: US 201562166583 P
[2018/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016191504
Date:01.12.2016
Language:EN
[2016/48]
Type: A1 Application with search report 
No.:EP3304041
Date:11.04.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 01.12.2016 takes the place of the publication of the European patent application.
[2018/15]
Type: B1 Patent specification 
No.:EP3304041
Date:10.03.2021
Language:EN
[2021/10]
Search report(s)International search report - published on:KR01.12.2016
(Supplementary) European search report - dispatched on:EP10.10.2018
ClassificationIPC:G01N15/14, G01N33/483, G01N33/49
[2018/15]
CPC:
C12Q1/6886 (EP,US); G01N33/4833 (US); G01N33/5044 (EP,US);
G01N33/5094 (EP,US); G01N33/57415 (EP,US); C12Q2600/158 (EP,US);
G01N2333/71 (EP,US); G01N2333/723 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/15]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERFAHREN ZUR BEURTEILUNG VON ZELLPROBEN AUS DER BRUST UND ZUSAMMENSETZUNGEN ZUR VERWENDUNG BEI DER DURCHFÜHRUNG DAVON[2018/15]
English:METHODS OF ASSESSING CELLULAR BREAST SAMPLES AND COMPOSITIONS FOR USE IN PRACTICING THE SAME[2018/15]
French:PROCÉDÉS D'ÉVALUATION D'ÉCHANTILLONS DE CELLULES MAMMAIRES ET COMPOSITIONS DESTINÉES À ÊTRE UTILISÉES DANS LA MISE EN UVRE DE CEUX-CI[2018/15]
Entry into regional phase23.11.2017National basic fee paid 
23.11.2017Search fee paid 
23.11.2017Designation fee(s) paid 
23.11.2017Examination fee paid 
Examination procedure23.11.2017Examination requested  [2018/15]
23.11.2017Date on which the examining division has become responsible
30.04.2019Amendment by applicant (claims and/or description)
17.06.2019Despatch of a communication from the examining division (Time limit: M06)
10.12.2019Reply to a communication from the examining division
04.03.2020Despatch of a communication from the examining division (Time limit: M04)
26.06.2020Reply to a communication from the examining division
30.09.2020Communication of intention to grant the patent
02.02.2021Fee for grant paid
02.02.2021Fee for publishing/printing paid
02.02.2021Receipt of the translation of the claim(s)
Opposition(s)13.12.2021No opposition filed within time limit [2022/07]
Fees paidRenewal fee
11.05.2018Renewal fee patent year 03
15.05.2019Renewal fee patent year 04
23.11.2020Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.202005   M06   Fee paid on   23.11.2020
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.05.2016
AL10.03.2021
AT10.03.2021
CY10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
IT10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
MK10.03.2021
MT10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SI10.03.2021
SK10.03.2021
SM10.03.2021
IE25.05.2021
LU25.05.2021
BE31.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
[2024/42]
Former [2024/22]HU25.05.2016
AL10.03.2021
AT10.03.2021
CY10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
IT10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
MK10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SI10.03.2021
SK10.03.2021
SM10.03.2021
IE25.05.2021
LU25.05.2021
BE31.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
Former [2023/30]HU25.05.2016
AL10.03.2021
AT10.03.2021
CY10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
IT10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SI10.03.2021
SK10.03.2021
SM10.03.2021
IE25.05.2021
LU25.05.2021
BE31.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
Former [2023/29]HU25.05.2016
AL10.03.2021
AT10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
IT10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SI10.03.2021
SK10.03.2021
SM10.03.2021
IE25.05.2021
LU25.05.2021
BE31.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
Former [2022/34]AL10.03.2021
AT10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
IT10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SI10.03.2021
SK10.03.2021
SM10.03.2021
IE25.05.2021
LU25.05.2021
BE31.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
Former [2022/23]AL10.03.2021
AT10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
IT10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SI10.03.2021
SK10.03.2021
SM10.03.2021
IE25.05.2021
LU25.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
Former [2022/21]AL10.03.2021
AT10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SI10.03.2021
SK10.03.2021
SM10.03.2021
IE25.05.2021
LU25.05.2021
CH31.05.2021
LI31.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
PT12.07.2021
Former [2022/11]AL10.03.2021
AT10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SI10.03.2021
SK10.03.2021
SM10.03.2021
LU25.05.2021
CH31.05.2021
LI31.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
PT12.07.2021
Former [2022/10]AL10.03.2021
AT10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SK10.03.2021
SM10.03.2021
LU25.05.2021
CH31.05.2021
LI31.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
PT12.07.2021
Former [2022/08]AL10.03.2021
AT10.03.2021
CZ10.03.2021
DK10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SK10.03.2021
SM10.03.2021
LU25.05.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
Former [2022/07]AL10.03.2021
AT10.03.2021
CZ10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
MC10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SK10.03.2021
SM10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
Former [2021/52]AT10.03.2021
CZ10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
NL10.03.2021
PL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SK10.03.2021
SM10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
Former [2021/51]AT10.03.2021
CZ10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
NL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SK10.03.2021
SM10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
IS10.07.2021
PT12.07.2021
Former [2021/50]AT10.03.2021
CZ10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
NL10.03.2021
RO10.03.2021
RS10.03.2021
SE10.03.2021
SK10.03.2021
SM10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
PT12.07.2021
Former [2021/48]AT10.03.2021
CZ10.03.2021
EE10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
NL10.03.2021
RS10.03.2021
SE10.03.2021
SM10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
Former [2021/46]AT10.03.2021
FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
NL10.03.2021
RS10.03.2021
SE10.03.2021
SM10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
Former [2021/43]FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
NL10.03.2021
RS10.03.2021
SE10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
Former [2021/38]FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
RS10.03.2021
SE10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
Former [2021/37]FI10.03.2021
HR10.03.2021
LT10.03.2021
LV10.03.2021
RS10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
Former [2021/36]FI10.03.2021
HR10.03.2021
LT10.03.2021
BG10.06.2021
NO10.06.2021
GR11.06.2021
Former [2021/35]FI10.03.2021
HR10.03.2021
LT10.03.2021
NO10.06.2021
Former [2021/33]FI10.03.2021
LT10.03.2021
NO10.06.2021
Documents cited:Search[A]WO2006113747  (PREDICTION SCIENCES LLC [US]) [A] 1-15 * paragraph [0054]; claims 1-19 *;
 [XY]US2012122078  (PATTERSON BRUCE K [US]) [X] 12-15 * paragraph [0044] - paragraph [0079]; claims 1-34 * [Y] 1-15;
 [Y]  - QI-YANG HE ET AL, INTERNATIONAL JOURNAL OF ONCOLOGY, (2002), vol. 20, pages 261 - 266, XP002785082 [Y] 1-15 * the whole document *
 [XY]  - AWTAR KRISHAN ET AL, "Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis", DIAGNOSTIC CYTOPATHOLOGY., US, (20060101), vol. 34, no. 8, doi:10.1002/dc.20496, ISSN 8755-1039, pages 528 - 541, XP055387408 [X] 1-3,5-7,10-15 * the whole document * [Y] 1-15

DOI:   http://dx.doi.org/10.1002/dc.20496
 [Y]  - BUSHRA SIKANDAR ET AL, "Differential immune cell densities in ductal carcinoma In-Situ and invasive breast cancer: Possible role of leukocytes in early stages of carcinogenesis", PAKISTAN JOURNAL OF MEDICAL SCIENCES, (20150128), vol. 31, no. 2, doi:10.12669/pjms.312.6481, XP055509407 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.12669/pjms.312.6481
International search[Y]US5798827  (FRANK ROBERT S [US], et al) [Y] 13, 15 * See column 1, lines 6-14; column 3, line 51-column 11, line 51; claims 1-45; and figure 1. *;
 [XY]WO0026666  (CELL WORKS INC [US], et al) [X] 12 * See pages 5-27; and claims 1-58. * [Y] 2, 3;
 [A]WO2007089880  (UNIV GEORGETOWN [US], et al) [A] 1-3, 7-9, 12-15* See the whole document. *;
 [A]US2012142089  (PARK JONG-MYEON [KR]) [A] 1-3, 7-9, 12-15 * See paragraphs [0010]-[0054]; and claims 1-20. *;
 [XYA]US8548219  (ORTYN WILLIAM [US], et al) [X] 1, 7-9, 14 * See column 2, line 55-column 29, line 6; claims 1-20; and figure 1A. * [Y] 2, 3, 13, 15 [A] 12
by applicant   - SCHWARTZ et al., West J Med., (20000000), vol. 173, no. 5, pages 307 - 312
    - SAHA et al., J. Cytol., (20130000), vol. 30, no. 2, pages 87 - 93
    - "R: A Language and Environment for Statistical Computing", R Core Team, (20140000), URL: www(dot)R-project(dot)org
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.